Therapeutic efficacy of a human papillomavirus type 16 E7 bacterial exotoxin fusion protein adjuvanted with CpG or GPI-0100 in a preclinical mouse model for HPV-associated disease |
| |
Institution: | 1. Department of Obstetrics & Gynecology, University of Southern California, Los Angeles, CA 90033, USA;2. Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA;3. Department of Molecular Microbiology & Immunology, University of Southern California, Los Angeles, CA 90033, USA;4. TheVax Genetics Vaccine Co., Ltd, Zhubei City, Hsinchu County 302, Taiwan, ROC;5. TheVax Genetics Vaccine Co., Ltd, Irvine, CA 92618, USA |
| |
Abstract: | Persistent human papillomavirus (HPV) infection is causally linked to the development of several human cancers, including cervical, vulvar, vaginal, anal, penile, and oropharyngeal cancers. To address the need for a therapeutic vaccine against HPV-associated diseases, here we test and compare the immunogenicity and therapeutic efficacy of a bacterial exotoxin fusion protein covalently linked to the HPV16 E7 oncoprotein adjuvanted with CpG or GPI-0100 in the C3.43 preclinical HPV16-transformed tumor model. We show that TVGV-1 protein vaccine adjuvanted with either CpG or GPI-0100 adjuvant induces a high frequency of E7-specific CD8+ T cells, and both adjuvants are able to assist the immune response in inducing polyfunctional cytokine-secreting lytic T cells that show therapeutic efficacy against well-established C3.43 tumors. CpG-adjuvanted TVGV-1 resulted in higher frequencies of IFNγ secreting and degranulating E7-specific T cells compared to GPI-0100-adjuvanted TVGV-1, resulting in marginally increased in vivo efficacy. Despite minor differences in immune response outcomes, we consider both CpG ODN and GPI-0100 to be promising vaccine adjuvants to increase the immunogenicity and therapeutic efficacy of the TVGV-1 protein for HPV16-driven cancers. |
| |
Keywords: | Human papillomavirus Therapeutic vaccine CpG adjuvant GPI-0100 adjuvant HPV16-induced tumors |
本文献已被 ScienceDirect 等数据库收录! |
|